Keensight Capital
Paris, Île-de-Francekeensightcapital.com
Overview
Keensight Capital is a European private equity firm focused on Growth Buyout investments within the Technology and Healthcare sectors. The firm partners with profitable, fast-growing companies, providing capital, strategic guidance, and operational support to help implement their growth strategies. Keensight targets companies across Europe with revenues typically ranging from €10 million to €400 million.
Portfolio Companies
8
Website
keensightcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bedfont Scientific | Oct 2025 | Buyout/LBO | Lead |
| Isto Biologics | Sep 2025 | Buyout/LBO | Lead |
| MetaCompliance | Feb 2025 | Buyout/LBO | Lead |
| 3PBIOVIAN | Feb 2024 | M&A | Lead |
| Aprovall | Jul 2023 | Private Equity | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.